Purchase Order 12234920P0003
- Not listed
- Luminex Corp, a Austin-based manufacturer of advanced biological testing technologies, was awarded a $6,661 firm fixed-price purchase order by a civilian Northeast Area federal agency on August 25, 2015. The service contract, designated LX10011206403 for BIORAD, was performed in Calverton, Maryland, and ran through August 31, 2016. This procurement was not set aside for any particular business category and represents Luminex's ongoing supply of specialized diagnostic products and services to...
- This is a $20,046.00 firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Luminex Corp, a foreign-owned manufacturer of biological testing technologies. The contract is for preventative maintenance services on Luminex's MAGPIX analyzers, which are multiplex diagnostic platforms used by the government for clinical testing, public health surveillance, and biomedical research. Luminex holds several significant federal contract...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The $20,046.00 contract is for preventative maintenance services on a MAGPIX system, a proprietary multiplex diagnostic platform used in clinical laboratories and life science research. Luminex often serves as a prime contractor to federal agencies, providing...
- The U.S. federal government awarded a $16.8K firm fixed-price purchase order to Luminex Corp for maintenance and service support of Guava EasyCyte laboratory equipment. The contract was awarded on September 27, 2019, with performance completion on September 27, 2020, and will be performed at a location in Portland, Oregon. This procurement was issued by a civilian agency within the Pacific West Area and was not designated as a set-aside contract, indicating that Luminex Corp competed on an...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $30,515 firm fixed-price purchase order to Luminex Corp for the MAGPIX XPONENT System IVD on September 14, 2023, with completion targeted for October 16, 2023. The contract covers the delivery of the MAGPIX-XPON4 system, a multiplex diagnostic platform used for advanced biological testing. Luminex Corp, headquartered in Austin, Texas, is a recognized manufacturer of specialized diagnostic technologies and has established itself as a...
- The U.S. federal government awarded a $14,292 firm fixed price purchase order to Luminex Corp for Luminex 200 MAGPLEX beads, with an ultimate completion date of February 10, 2017. The contract was awarded without a set-aside designation on January 3, 2017, and is being performed in Austin, Texas. Luminex Corp, a manufacturer of advanced biological testing technologies, was selected to provide these specialized microspheres, which are critical components used in the company's multiplex diagnostic...
- This is a Firm Fixed Price Delivery Order awarded by the Medical Supply Chain division of the U.S. Department of Defense to Luminex Corp, a foreign-owned, for-profit manufacturer of advanced biological testing technologies headquartered in Austin, Texas. The $1,902.36 contract is for the supply of MAGPLEX, 1 ML, REGION 51 items. Luminex has been awarded several significant federal Indefinite Delivery Vehicles, including a $5,762,500 Blanket Purchase Agreement with the Air Force's 711th Human...
- Luminex Corp, a foreign-owned manufacturer of advanced biological testing technologies based in Austin, Texas, was awarded a delivery order valued at $9,420.84 for MAGPLEX 1 ML products in Region 09. The contract, which was not set aside for any specific category of vendors, was awarded on September 2, 2025, with an ultimate completion date of September 5, 2025. The award was funded by the Medical Supply Chain division within the Department of Defense and will be performed at Luminex's...
- The Defense Health Agency awarded a $40,092 firm fixed-price purchase order to Luminex Corp on September 22, 2023, for base year maintenance and service of a Luminex MAGPIX multiplexing machine. The contract is scheduled for completion by September 21, 2026, and does not utilize a set-aside designation. Performance will take place at Aberdeen Proving Ground in Maryland. Luminex Corp, headquartered in Austin, Texas, specializes in advanced biological testing technologies and multiplex...
- This is a firm-fixed-price purchase order awarded by the Department of the Army Medical Command to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies and multiplex diagnostic solutions. The contract is for $128,757.86 and the period of performance is through October 13, 2017. The contract is not designated as a set-aside. Luminex provides immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing...
The U.S. government awarded a purchase order valued at $14,665.60 to Luminex Corp for maintenance and support services related to MAGPIX GOLD equipment. The contract was awarded on September 23, 2020, with an ultimate completion date of September 19, 2023. This firm fixed-price purchase order was issued by a civilian federal agency within the Northeast Area and will be performed in Orient, NY. No set-aside designation was utilized for this competitive award. Luminex Corp, a for-profit manufacturer of advanced biological testing technologies headquartered in Austin, Texas, specializes in multiplex diagnostic solutions and laboratory equipment maintenance. The company maintains multiple indefinite delivery vehicles across federal agencies, including blanket purchase agreements with the Air Force, USDA Veterinary Services, and the Department of Veterans Affairs for diagnostic reagents and testing services. This particular purchase order represents routine maintenance support for the MAGPIX GOLD platform, a diagnostic instrument commonly used across federal laboratories and research facilities for multiplexing assay applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | ($1) | 8/27/25 | |
| P00003 | Exercise an Option | $4.9k | 5/11/22 | |
| P00002 | Exercise an Option | $4.9k | 4/22/21 | |
| P00001 | Other Administrative Action | $0 | 9/23/20 | |
| Not listed | Not listed | $4.9k | 9/23/20 |